Cancer Diabetes Patients Show Better Survival with Metformin

An analysis of 13,008 cancer patients with concurrent type 2 diabetes showed that those who took metformin attained better overall survival compared with those who took other diabetes medications. However, it is still unclear whether metformin may help modulate results in such patients, researchers wrote. First published online November 20, 2013 doi: 10.1634/theoncologist.2013-0111